Back to VRTX

VERTEX PHARMACEUTICALS INC / MA Prepaid & Other Current Assets 2010-2026 | VRTX

Beta

What is prepaid & other current assets?

Prepaid and other current assets include advance payments and other assets expected to be consumed or converted to cash within one year.

What is VERTEX PHARMACEUTICALS INC / MA's current prepaid & other current assets?

VERTEX PHARMACEUTICALS INC / MA (VRTX) annual prepaid & other current assets for 2025 was $853.3M, a 28.18% increase from 2024. VERTEX PHARMACEUTICALS INC / MA prepaid & other current assets for the quarter ending March 31, 2026 was $720.8M.

What was VERTEX PHARMACEUTICALS INC / MA's prepaid & other current assets in 2024?

VERTEX PHARMACEUTICALS INC / MA annual prepaid & other current assets for 2024 was $665.7M, a 6.73% increase from 2023.

What was VERTEX PHARMACEUTICALS INC / MA's prepaid & other current assets in 2023?

VERTEX PHARMACEUTICALS INC / MA annual prepaid & other current assets for 2023 was $623.7M, a 12.68% increase from 2022.

What is VERTEX PHARMACEUTICALS INC / MA's 5-year prepaid & other current assets CAGR?

VERTEX PHARMACEUTICALS INC / MA prepaid & other current assets grew at a compound annual growth rate (CAGR) of 22.58% from FY2020 to FY2025, going from $308.3M to $853.3M over 5 years.

Prepaid & Other Current Assets History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+22.6%
FY2020
$308.3M
FY2025
$853.3M
10111213141516171819202122232425
5 years selected
Prepaid & Other Current Assets History
PeriodValueChangeSource
FY2025$853.3M+28.2%10-K
FY2024$665.7M+6.7%10-K
FY2023$623.7M+12.7%10-K
FY2022$553.5M+1.4%10-K
FY2021$545.8M+77.0%10-K
FY2020$308.3M+44.4%10-K
FY2019$213.5M+51.6%10-K
FY2018$140.8M-15.7%10-K
FY2017$167.1M+134.6%10-K
FY2016$71.3M+30.2%10-K
FY2015$54.7M+23.9%10-K
FY2014$44.2M+85.3%10-K
FY2013$23.8M-3.4%10-K
FY2012$24.7M+65.7%10-K
FY2011$14.9M+13.7%10-K
FY2010$13.1M-10-K
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →